Drug Discovery Featured Articles & Applications
-
Biotech Patenting: 4 Tips & Personal Experiences
9/13/2021
When you file for patent protection for your discoveries, keep these 4 tips in mind. I also share some of my personal experiences with patenting from over the course of the last 28 years, from when I cofounded 180 Life Sciences through now.
-
How To Find & Manage Biotech Consultants Effectively
9/6/2021
The roles being filled by biotech consultants have grown considerably, as companies are becoming more familiar with working with consultants and more people are interested in pursuing a consultant career. But how do we find good consultants, and how do we ensure that our consultants are as committed and engaged as our full-time employees? Here's how to accomplish that.
-
What’s The Role Of Interim Consultants In The Life Sciences & How Do We Use Them Effectively?
9/3/2021
When life sciences companies need new talent, they typically have two options: bring in a consultant or hire a full-time employee. Usually, this decision is dictated by the permanence of the role, but sometimes, timelines complicate things. In this situation, an interim consultant can be the solution. But what is the interim consultant's role, really, and how do we use them effectively?
-
3 Successful Strategies For Protecting Your New Biopharma’s IP
9/1/2021
Intellectual property is the lifeblood of new biopharma entities. Patent protection is necessary to secure investment, to build a solid foundation with opportunity for future growth, and to establish viability within a highly competitive landscape. This article addresses key patent-related considerations for startups and small or early-stage players in the life sciences arena.
-
Best Practices For Raw Material Supplier Change Notifications: New BioPhorum Guidance
8/27/2021
Managing the large volume of supplier change notifications while safeguarding the continuity and compliance of a complex and tightly regulated supply chain is a resource-intensive task. To address the challenges, the BioPhorum Raw Material Variability Workstream has developed a guidance document designed to streamline the process without straying from essential and strict risk mitigation procedures.
-
Best Practices To Ensure Quality Of Raw Materials Used To Manufacture Therapeutic Proteins
8/25/2021
Across biologics, raw material quality is a key driver of product quality and consistency. This article recaps a recent U.S. Pharmacopeia (USP) workshop on the subject, including recaps of best practices and experiences shared by the FDA, Merck, Biogen, and more.
-
Are You Outsourcing Your Future?
8/20/2021
Today drug development and manufacturing outsourcing is a ubiquitous business-enabling activity to gain entrée to advanced technologies and capabilities. Those are the capabilities upon which your programs and overall organization are centered. Are you, then, outsourcing your future?
-
SARS-CoV-2: Massey Univ. Profs Develop Method To Quickly Sequence Genome
8/13/2021
It was a matter of time before the world saw variants emerge that increased the transmission rate of COVID-19. A research team led by two of these authors at Massey University have developed a new next-generation sequencing method for the ultrafast sequencing of the SARS-CoV-2 genome, which cuts the sequencing time by more than half.
-
Decoding The Immune Synapse To Create Novel Immunotherapies
8/2/2021
The potential of T cell therapies to be curative by harnessing our own immune repertoire has exciting implications for cancer and many other immune-mediated disorders.
-
New Discoveries For Hemophilia A
7/30/2021
The Mayo Clinic describes Hemophilia A as a rare, inherited disorder in which the blood doesn't clot normally, because it lacks sufficient blood-clotting proteins (clotting factors). People with hemophilia may bleed for a longer time after an injury than they would if their blood clotted normally. Hemophilia A, also known as classical hemophilia, is a genetic bleeding disorder caused by insufficient levels of a blood protein called factor VIII, which is a clotting factor.